Doxycycline suppresses Chlamydia pneumoniae-mediated increases in ongoing immunoglobulin E and interleukin-4 responses by peripheral blood mononuclear cells of patients with allergic asthma

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 10, 2013, Pages 2363-2368

  Dzhindzhikhashvili, M S ^a   Joks, Rauno ^a   Smith Norowitz, Tamar ^a   Durkin, Helen G ^a   Chotikanatis, Kobkul ^a   Estrella, Eva ^a   Hammerschlag, Margaret R ^a   Kohlhoff, Stephan A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cytokines; Immunomodulation; Inflammation; Tetracyclines

Indexed keywords

DOXYCYCLINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ADULT; ALLERGIC ASTHMA; ARTICLE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SUPERNATANT;

CYTOKINES; IMMUNOMODULATION; INFLAMMATION; TETRACYCLINES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ASTHMA; BACTERIAL LOAD; CELLS, CULTURED; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DOXYCYCLINE; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84888808366     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt179     Document Type: Article

References (41)

1. Emre U, Roblin PM, Gelling M et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-31.
2. Biscione GL, Corne J, Chauhan AJ et al. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Resp J 2004; 24: 745-9.
3. Hammerschlag MR, Chirgwin K, Roblin PM et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14: 178-82.
4. Martin RJ, Kraft M, Chu HW et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107: 595-601.
5. Emre U, Sokolovskaya N, Roblin PM et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995; 172: 265-7.
6. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae. A role in asthma pathogenesis? Am J Respir Crit Care Med 2005; 172: 1078-89.
7. Johnston SL, Blasi F, Black PN et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006; 354: 1589-600.
8. Hammerschlag MR, Kohlhoff SA. Treatment of chlamydial infections. Expert Opin Pharmacother 2012; 13: 545-52.
9. Hammerschlag MR, Kohlhoff SA, Darville T. Chlamydial infections and chronic diseases. In: Fratamico PM, Smith JL, Brogden KA, eds. Post-Infectious Sequelae and Long-Term Consequences of Infectious Diseases. Washington, DC: American Society for Microbiology Press, 2008; 27-52.
10. Daoud A, Gloria CJ, Taningco G et al. Minocycline treatment results in reduced oral steroid requirements in adults. Asthma. Allergy Asthma Proc 2008; 29: 286-94.
11. Richeldi L, Ferrara G, Fabbri LM et al. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005; issue 4: CD002997.
12. Golub L, Ramamurthy N, McNamara T et al. Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res 1984; 19: 651-5.
13. Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011; 63: 130-45.
14. Smith-Norowitz TA, Bluth MH, Drew H et al. Effect of minocycline and doxycycline on IgE responses. Ann Allergy Asthma Immunol 2002; 89: 172-9.
15. Kohlhoff SA, Dzhindzhikhashvili M, Smith-Norowitz T et al. Peripheral blood mononuclear cells (PBMC) in allergic asthmatics with serologic evidence of prior Chlamydia pneumoniae (Cpn) infection contain activated cells that continue to secrete IgE ex vivo. J Allergy Clin Immunol 2009; 123 Suppl: S170, Abstract 648.
16. National Heart, Lung, and Blood Institute, and National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007; 40-3. http://www.nhlbi. nih.gov/guidelines/asthma/asthgdln.pdf (8 March 2013, date last accessed).
17. Wong DM, Blumberg DA, Lowe LG. Guidelines for the use of antibiotics in acute upper respiratory tract infections. Am Fam Physician 2006; 74: 956-66.
18. Roblin PM, Dumornay W, Hammerschlag MR. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992; 30: 1968-71.
19. Apfalter P, Barousch W, Nehr M et al. Comparison of a new quantitative ompA-based real-time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays. J Clin Microbiol 2003; 41: 592-600.
20. Waring AL, Halse TA, Csiza CK et al. Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. J Clin Microbiol 2001; 39: 1385-90.
21. von Hertzen LC. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J 2002; 19: 546-56.
22. Paul WE, Zhu J. Howare TH2-type responses initiated and amplified? Nat Rev Immunol 2010; 10: 225-35.
23. Halme S, Latvala J, Karttunen R et al. Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect Immun 2000; 68: 7156-8.
24. Wang S, Fan Y, Brunham RC et al. IFN-g knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol 1999; 29: 3782-92.
25. Papadopoulos NG, Konstantinou GN. Antimicrobial strategies: anoption to treat allergy? Biomed Pharmacother 2007; 61: 21-8.
26. Sutherland ER, King TS, Icitovic N et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010; 126: 747-53.
27. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther 2005; 27: 1329-42.
28. Joks R, Durkin H. Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs. Pharmacol Res 2011; 64: 602-9.
29. Kuzin II, Snyder JE, Ugine GD et al. Tetracyclines inhibit activated B cell function. Int Immunol 2001; 13: 921-31.
30. Thong YH, Ferrante A. Effect of tetracycline treatment on immunological responses in mice. Clin Exp Immunol 1980; 39: 728-32.
31. Ingham E, Turnbull L, Kearney JN. The effects of minocycline and tetracycline on the mitotic response of human peripheral blood lymphocytes. J Antimicrob Chemother 1991; 27: 607-17.
32. Geng Y, Berencsi K, Gyulai Z et al. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun 2000; 68: 2245-53.
33. Rottenberg ME, Gigliotti Rothfuchs AC et al. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 1999; 162: 2829-36.
34. Wolf K, Fischer E, Hackstadt. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect Immun 2005; 73: 4560-70.
35. Roblin PM, Montalban G, Hammerschlag MR. Susceptibilities of clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. Antimicrob Agents Chemother 1994; 38: 1588-9.
36. Poikonen K, Lajunen T, Silvennoinen-Kassinen S et al. Quantification of Chlamydia pneumoniae in cultured human macrophages and HL cells: comparison of real-time PCR, immunofluorescence and ELISA methods. APMIS 2010; 118: 45-8.
37. Hartnett BJS, Marlin GE. Doxycycline in serum and bronchial secretions. Thorax 1976; 31: 144-8.
38. Roblin PM, Hammerschlag MR. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis. Int J Antimicrob Agents 2000; 16: 61-3.
39. Skidmore R, Kovach R, Walker C et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003; 139: 459-64.
40. Mukouyama T, Ito W, Ichikawa K et al. Spontaneous IgE production in asthmatic children. Arerugi 1994; 43: 474-81.
41. Airenne S, Surcel HM, Alakarppa H et al. Chlamydiapneumoniae infection in human monocytes. Infect Immun 1999; 67: 1445-9.